What question did this study set out to answer?

This research aims to explore the implications of GLP-1 weight-loss injections on health through poisoning data.

February 16, 2026

Weighing the hype: What poisonings data reveals about the weight loss drug boom

Key Points

This research aims to explore the implications of GLP-1 weight-loss injections on health through poisoning data.
Analyzed data from US poison centers
Assessed incidents related to GLP-1 injections like Ozempic and Wegovy
Identified trends in poisoning cases linked to these medications
Documented a rise in poisoning incidents associated with GLP-1 injections
Highlighted potential safety concerns amid the weight-loss drug boom
Showed a correlation between increased prescriptions and poisoning reports

Abstract

Abstract As new GLP-1 weight-loss injections like Ozempic, Wegovy and Mounjaro reshape medicine and culture, Jordan G. Miller, Robert S. Miller, Shawn M. Varney and David Han demonstrate how US poison centres are quietly documenting the growing pains of a pharmaceutical revolution

Mark Helpful

Bookmark

Relay